Antioxidant-based poly(anhydride-esters)

US9862672B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9862672-B2
Application numberUS-201414894166-A
CountryUS
Kind codeB2
Filing dateMay 29, 2014
Priority dateMay 29, 2013
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Certain embodiments of the invention provide antioxidant-based diacids and polymers comprising glycol groups as described herein, and methods of use thereof. In certain embodiments the polymers described herein are formulated as microspheres or hydrogels. Described herein is the chemical incorporation of antioxidants, e.g., coumaric acid, ferulic acid, and sinapic acid, into a polymer backbone for use, e.g., in applications for localized release and rapid delivery. As provided, the chemical composition of the linker molecules used (of which hold together two bioactives via ester linkages) may be used to vary the hydrophilicity of the polymer. The bioactive release rate may also be altered for a tunable release delivery system, allowing for increased bioactive release compared to other linkers previously utilized.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymer selected from: wherein R 1 is OCH 3 and R 2 is H; R 1 is OCH 3 and R 2 is OCH 3 ; or R 1 is H and R 2 is H; wherein y is 4 or more; and wherein n is 2 or more. 2. The polymer of claim 1 , wherein R 1 is OCH 3 and R 2 is H. 3. The polymer of claim 1 , wherein R 1 is OCH 3 and R 2 is OCH 3 . 4. The polymer of claim 1 , wherein R 1 is H and R 2 is H. 5. A microsphere comprising the polymer as described in claim 1 . 6. A diacid selected from: wherein R 1 is OCH 3 and R 2 is H; R 1 is OCH 3 and R 2 is OCH 3 ; or R 1 is H and R 2 is H; and wherein y is 4 or more. 7. A pharmaceutical composition comprising the polymer as described in claim 1 and a pharmaceutically acceptable carrier. 8. A cosmetic comprising the polymer as described in claim 1 . 9. A sunscreen comprising the polymer as described in claim 1 . 10. A method of reducing oxidative stress in a cell of a mammal, preventing photodamage in skin of a mammal, and/or treating a disorder associated with oxidative stress in a mammal, comprising administering the polymer as described in claim 1 to the mammal. 11. The method of claim 10 , wherein the polymer is administered topically. 12. A hydrogel comprising a blend comprising (a) the polymer as described in claim 1 and (b) a hydrophilic polymer. 13. The hydrogel of claim 12 , wherein the hydrophilic polymer is selected from the group consisting of poly(N-vinyl-2-pyrrolidone), poly(vinyl alcohol), and poly(ethylene oxide). 14. The hydrogel of claim 13 , wherein the hydrophilic polymer is poly(N-vinyl-2-pyrrolidone). 15. The hydrogel of claim 12 , wherein the polymer as described in claim 1 is physically crosslinked with the hydrophilic polymer through hydrophobic interactions. 16. A method of making a hydrogel comprising blending and solvent casting (a) the polymer as described in claim 1 and (b) a hydrophilic polymer, under conditions that provide a hydrogel. 17. The method of claim 16 , further comprising crosslinking (a) the polymer as described in claim 1 with (b) the hydrophilic polymer, wherein the crosslinking is by ultraviolet radiation, gamma radiation, or a crosslinking agent. 18. A method for promoting wound healing in a mammal, comprising contacting the hydrogel as described in claim 12 with a wound of the mammal. 19. A method of therapeutically treating the skin of a mammal, comprising contacting the hydrogel as described in claim 12 with the skin of the mammal.

Assignees

Inventors

Classifications

  • Explicitly spheroidal or spherical shape · CPC title

  • Esters of carboxylic acids · CPC title

  • Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations · CPC title

  • C07C69/734Primary

    Ethers · CPC title

  • C08G63/06Primary

    derived from hydroxycarboxylic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9862672B2 cover?
Certain embodiments of the invention provide antioxidant-based diacids and polymers comprising glycol groups as described herein, and methods of use thereof. In certain embodiments the polymers described herein are formulated as microspheres or hydrogels. Described herein is the chemical incorporation of antioxidants, e.g., coumaric acid, ferulic acid, and sinapic acid, into a polymer backbone …
Who is the assignee on this patent?
Univ Rutgers
What technology area does this patent fall under?
Primary CPC classification C07C69/734. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).